Similar Articles |
|
Chemistry World October 23, 2009 Matt Wilkinson |
What's in a pill? Buying cheap drugs over the internet is well known to be a risky business. But the sinister menace of the 'falsified' active pharmaceutical ingredient gets far less publicity. |
Pharmaceutical Executive June 1, 2014 |
Hopes High as EU Heads Into Leadership Change The principal drug industry associations in Europe launched a call in mid-May for "an integrated European industrial policy for the pharmaceuticals sector." |
Chemistry World August 2, 2007 Victoria Gill |
Europe Poised for a Surge in Generic Drugs The European Medicines Agency's Committee for Medicinal Products for Human use has recommended the approval of a schizophrenia treatment which is the first generic drug to be assessed under Europe's centralized procedure. |
Pharmaceutical Executive February 1, 2006 Sarah Houlton |
Global Report: Moving Towards Generic Biologics The European Medicines Agency hopes to complete its guidelines for the approval of biosimilar drugs early this year, paving the way for the approval of biogenerics - and a potential goldmine for the generics companies. |
Chemistry World May 2006 Bea Perks |
Editorial: Generics in the Dock The manufacturers of generic medicines in the U.K. must work harder to guard their good reputation. Or perhaps, manufacturers of generic medicines must work harder to counter their bad reputation. |
Pharmaceutical Executive July 1, 2005 Sarah Houlton |
Global Report: Still Waiting Pharma industry and traders both want a decision on parallel trade in Europe--but not the same one. |
Fast Company Rose Pastore |
Google Strikes Back Against Europe's Antitrust Charges Google published a blog post on Thursday responding to the European Commission's claims that some of its practices are anti-competitive. |
Chemistry World April 2007 Richard Barker |
Comment: Pricing Pills An Office of Fair Trading report claims The UK's National Health Service is paying over the odds for its drugs, but this is not so. Medicine prices are 21% lower in real terms than ten years ago. |